文献速递肝病

老年肝硬化患者的轻微肝性脑病与轻度认知障碍影响生活质量

Minimal Hepatic Encephalopathy and Mild Cognitive Impairment Worsen Quality of Life in Elderly Patients With Cirrhosis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-03-20

多中心研究纳入109例65岁以上肝硬化门诊患者和100例无肝硬化对照,评估轻微肝性脑病(MHE)和轻度认知障碍(MCI)及其对生活质量(QOL)的影响。MHE无论是否合并MCI均与认知和生活质量差相关,MCI+MHE组QOL最低;基于EncephalApp调整常模的MHE检出率49%,PHES为8%,并在77例验证队列中验证。

要点

  • 老年肝硬化患者中MHE与不良认知及生活质量相关,合并MCI时QOL最差。
  • EncephalApp调整常模对老年肝硬化患者MHE检出敏感性高,验证队列结果一致。
  • MHE合并MCI的评估有助于识别QOL受损更严重的老年肝硬化患者。

核心结论

  • 在65岁以上肝硬化患者中,MHE无论是否合并MCI均与认知功能差和生活质量差相关,MCI+MHE组生活质量最低。
  • 基于对照调整常模的EncephalApp对老年肝硬化患者MHE检测敏感性高,并在独立验证队列中得到验证。

研究设计与样本

  • 多中心研究,衍生队列纳入肝硬化门诊患者109例和无肝硬化对照100例,年龄均≥65岁。
  • 验证队列为同一研究中心的77例肝硬化患者(平均年龄69.49±4.36岁,72%男性)。
  • 肝硬化患者完成PHES、EncephalApp和生活质量评估,并用重复性神经心理状态评估量表检测MCI,分为无损害、仅MCI、仅MHE和MCI+MHE组。
  • 利用对照数据建立调整常模以检测MHE。

主要发现

  • 对照者年龄更大但教育程度更高、认知表现更好且生活质量更优。
  • 肝硬化患者中,年龄、教育、MELD评分、EncephalApp评分和生活质量在各中心相似,但PHES和重复性神经心理状态评估量表得分存在中心间差异。
  • 在衍生队列中,MHE(伴或不伴MCI)与生活质量差相关,MCI+MHE组生活质量最低。
  • 调整年龄、性别和教育后,衍生队列中基于EncephalApp的MHE比例为49%,基于PHES的MHE比例为8%。
  • 验证队列呈现相似模式:基于EncephalApp的MHE比例为49%,基于PHES的MHE比例为6%。

关键数值与推荐

  • 衍生队列调整年龄、性别和教育后,基于EncephalApp的MHE检出率为49%,基于PHES的MHE检出率为8%。
  • 验证队列中基于EncephalApp的MHE检出率为49%,基于PHES的MHE检出率为6%。

临床怎么用

  • 对65岁以上肝硬化患者可考虑使用EncephalApp辅助筛查MHE,其调整常模在该人群中敏感性高。
  • 同时评估MCI有助于识别生活质量受损更严重的老年肝硬化患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Patients with cirrhosis are growing older. The overlap between minimal hepatic encephalopathy (MHE) and predementia mild cognitive impairment (MCI) could affect quality of life (QOL). We investigated the performance of elderly patients with cirrhosis on tests for MHE and MCI and their effects on QOL. METHODS: We recruited outpatients with cirrhosis (n = 109) and without cirrhosis (controls, n = 100), 65 years or older, at 4 centers (derivation cohort). All study participants were assessed for psychometric hepatic encephalopathy score (PHES), EncephalApp score, and QOL. MCI was tested in patients with cirrhosis using the repeatable battery for assessment of neuropsychological status and assigned to the following groups: unimpaired, MCI only, MHE only, and MCI+MHE. We created adjusted norms to detect MHE using PHES and EncephalApp scores from the controls. Findings were validated using data from a separate cohort of 77 patients with cirrhosis (mean age, 69.49 ± 4.36 y; 72% men) at the same study sites. RESULTS: Controls were older but were more educated, performed better cognitively, and had better QOL. Among patients with cirrhosis, age, education, model for end-stage liver disease score, EncephalApp score, and QOL were similar, but PHES and repeatable battery for assessment of neuropsychological status differed among sites. In the derivation cohort, the presence of MHE, with or without MCI, was associated with poor QOL, which was lowest in the MCI+MHE group. When we adjusted for age, sex, and education, 49% of patients with cirrhosis had MHE based on the EncephalApp and 8% had MHE based on the PHES. A similar pattern (49% MHE based on EncephalApp and 6% MHE based on PHES) was found in a validation cohort. CONCLUSIONS: In a multicenter study of patients with cirrhosis (>65 y) and controls, the presence of MHE, regardless of MCI, was associated with poor cognition and QOL. We created adjusted norms that defined the high sensitivity of EncephalApp for the detection of MHE in older individuals and validated it in a separate cohort.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Bajaj JS, Duarte-Rojo A, Xie JJ, et al. Minimal Hepatic Encephalopathy and Mild Cognitive Impairment Worsen Quality of Life in Elderly Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2020. PMID: 32205222. doi:10.1016/j.cgh.2020.03.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。